Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect
Junzhu Wu,1,2,* Jingjing Zhao,1,3,* Bo Zhang,1 Yong Qian,1 Huile Gao,1 Yuan Yu,1 Yan Wei,1 Zhi Yang,1 Xinguo Jiang,1 Zhiqing Pang1 1Key Laboratory of Smart Drug Delivery, Ministry of Education, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, 2School of Pharmacy, Dali U...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/10fa0f5d8a5a40bab1d5d5d3c13e4b16 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:10fa0f5d8a5a40bab1d5d5d3c13e4b16 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:10fa0f5d8a5a40bab1d5d5d3c13e4b162021-12-02T04:05:36ZPolyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect1178-2013https://doaj.org/article/10fa0f5d8a5a40bab1d5d5d3c13e4b162014-11-01T00:00:00Zhttp://www.dovepress.com/polyethylene-glycolndashpolylactic-acid-nanoparticles-modified-with-cy-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013 Junzhu Wu,1,2,* Jingjing Zhao,1,3,* Bo Zhang,1 Yong Qian,1 Huile Gao,1 Yuan Yu,1 Yan Wei,1 Zhi Yang,1 Xinguo Jiang,1 Zhiqing Pang1 1Key Laboratory of Smart Drug Delivery, Ministry of Education, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, 2School of Pharmacy, Dali University, Xiaguan, 3School of Pharmacy, China Pharmaceutical University, Nanjing, People’s Republic of China *These authors contributed equally to this work Abstract: For a nanoparticulate drug-delivery system, crucial challenges in brain-glioblastoma therapy are its poor penetration and retention in the glioblastoma parenchyma. As a prevailing component in the extracellular matrix of many solid tumors, fibrin plays a critical role in the maintenance of glioblastoma morphology and glioblastoma cell differentiation and proliferation. We developed a new drug-delivery system by conjugating polyethylene glycol–polylactic acid nanoparticles (NPs) with cysteine–arginine–glutamic acid–lysine–alanine (CREKA; TNPs), a peptide with special affinity for fibrin, to mediate glioblastoma-homing and prolong NP retention at the tumor site. In vitro binding tests indicated that CREKA significantly enhanced specific binding of NPs with fibrin. In vivo fluorescence imaging of glioblastoma-bearing nude mice, ex vivo brain imaging, and glioblastoma distribution demonstrated that TNPs had higher accumulation and longer retention in the glioblastoma site over unmodified NPs. Furthermore, pharmacodynamic results showed that paclitaxel-loaded TNPs significantly prolonged the median survival time of intracranial U87 glioblastoma-bearing nude mice compared with controls, Taxol, and NPs. These findings suggested that TNPs were able to target the glioblastoma and enhance retention, which is a valuable strategy for tumor therapy. Keywords: CREKA peptide, nanoparticles, retention effect, paclitaxel, glioblastomaWu JZhao JZhang BQian YGao HYu YWei YYang ZJiang XPang ZDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 5261-5271 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Wu J Zhao J Zhang B Qian Y Gao H Yu Y Wei Y Yang Z Jiang X Pang Z Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect |
| description |
Junzhu Wu,1,2,* Jingjing Zhao,1,3,* Bo Zhang,1 Yong Qian,1 Huile Gao,1 Yuan Yu,1 Yan Wei,1 Zhi Yang,1 Xinguo Jiang,1 Zhiqing Pang1 1Key Laboratory of Smart Drug Delivery, Ministry of Education, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, 2School of Pharmacy, Dali University, Xiaguan, 3School of Pharmacy, China Pharmaceutical University, Nanjing, People’s Republic of China *These authors contributed equally to this work Abstract: For a nanoparticulate drug-delivery system, crucial challenges in brain-glioblastoma therapy are its poor penetration and retention in the glioblastoma parenchyma. As a prevailing component in the extracellular matrix of many solid tumors, fibrin plays a critical role in the maintenance of glioblastoma morphology and glioblastoma cell differentiation and proliferation. We developed a new drug-delivery system by conjugating polyethylene glycol–polylactic acid nanoparticles (NPs) with cysteine–arginine–glutamic acid–lysine–alanine (CREKA; TNPs), a peptide with special affinity for fibrin, to mediate glioblastoma-homing and prolong NP retention at the tumor site. In vitro binding tests indicated that CREKA significantly enhanced specific binding of NPs with fibrin. In vivo fluorescence imaging of glioblastoma-bearing nude mice, ex vivo brain imaging, and glioblastoma distribution demonstrated that TNPs had higher accumulation and longer retention in the glioblastoma site over unmodified NPs. Furthermore, pharmacodynamic results showed that paclitaxel-loaded TNPs significantly prolonged the median survival time of intracranial U87 glioblastoma-bearing nude mice compared with controls, Taxol, and NPs. These findings suggested that TNPs were able to target the glioblastoma and enhance retention, which is a valuable strategy for tumor therapy. Keywords: CREKA peptide, nanoparticles, retention effect, paclitaxel, glioblastoma |
| format |
article |
| author |
Wu J Zhao J Zhang B Qian Y Gao H Yu Y Wei Y Yang Z Jiang X Pang Z |
| author_facet |
Wu J Zhao J Zhang B Qian Y Gao H Yu Y Wei Y Yang Z Jiang X Pang Z |
| author_sort |
Wu J |
| title |
Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect |
| title_short |
Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect |
| title_full |
Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect |
| title_fullStr |
Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect |
| title_full_unstemmed |
Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect |
| title_sort |
polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect |
| publisher |
Dove Medical Press |
| publishDate |
2014 |
| url |
https://doaj.org/article/10fa0f5d8a5a40bab1d5d5d3c13e4b16 |
| work_keys_str_mv |
AT wuj polyethyleneglycolndashpolylacticacidnanoparticlesmodifiedwithcysteinendashargininendashglutamicacidndashlysinendashalaninefibrinhomingpeptideforglioblastomatherapybyenhancedretentioneffect AT zhaoj polyethyleneglycolndashpolylacticacidnanoparticlesmodifiedwithcysteinendashargininendashglutamicacidndashlysinendashalaninefibrinhomingpeptideforglioblastomatherapybyenhancedretentioneffect AT zhangb polyethyleneglycolndashpolylacticacidnanoparticlesmodifiedwithcysteinendashargininendashglutamicacidndashlysinendashalaninefibrinhomingpeptideforglioblastomatherapybyenhancedretentioneffect AT qiany polyethyleneglycolndashpolylacticacidnanoparticlesmodifiedwithcysteinendashargininendashglutamicacidndashlysinendashalaninefibrinhomingpeptideforglioblastomatherapybyenhancedretentioneffect AT gaoh polyethyleneglycolndashpolylacticacidnanoparticlesmodifiedwithcysteinendashargininendashglutamicacidndashlysinendashalaninefibrinhomingpeptideforglioblastomatherapybyenhancedretentioneffect AT yuy polyethyleneglycolndashpolylacticacidnanoparticlesmodifiedwithcysteinendashargininendashglutamicacidndashlysinendashalaninefibrinhomingpeptideforglioblastomatherapybyenhancedretentioneffect AT weiy polyethyleneglycolndashpolylacticacidnanoparticlesmodifiedwithcysteinendashargininendashglutamicacidndashlysinendashalaninefibrinhomingpeptideforglioblastomatherapybyenhancedretentioneffect AT yangz polyethyleneglycolndashpolylacticacidnanoparticlesmodifiedwithcysteinendashargininendashglutamicacidndashlysinendashalaninefibrinhomingpeptideforglioblastomatherapybyenhancedretentioneffect AT jiangx polyethyleneglycolndashpolylacticacidnanoparticlesmodifiedwithcysteinendashargininendashglutamicacidndashlysinendashalaninefibrinhomingpeptideforglioblastomatherapybyenhancedretentioneffect AT pangz polyethyleneglycolndashpolylacticacidnanoparticlesmodifiedwithcysteinendashargininendashglutamicacidndashlysinendashalaninefibrinhomingpeptideforglioblastomatherapybyenhancedretentioneffect |
| _version_ |
1718401412323344384 |